eMEMBERSHIP  LOGIN

Jellyfish Protein Helps to Improve Cognitive Function

Posted on July 23, 2010, 6 a.m. in Brain and Mental Performance Neurology

Apoaequorin, a protein found in jellyfish, helps to boost cognitive function in people with memory problems.  In a study involving 35 adults, average age 61 years, who reported memory concerns, apoaequorin improved scores on cognitive tests by 14% in 60 days. It is posited that apoaequorin, a calcium-binding protein, replaces proteins depleted with aging and that contribute to cognitive issues.    Because this unique mechanism slows the cellular events that can lead to neurotoxicity, researchers are hopeful this jellyfish protein may be of benefit for a variety of other neurological conditions. 

View news source…

“Quincy Bioscience Receives Patent for Jellyfish Protein Aequorin,” Quincy Bioscience, July 8, 2010.

  

Health Headlines MORE »

The amount of choline needed by people varies significantly and is dependent upon their gender, life stage, race and ethnicity.
People who develop diabetes and high blood pressure in middle-age are at increased risk of brain damage and problems with thinking skills later in life.
Currently available drugs may help women at high risk of breast and ovarian cancers avoid the need for radical preventive surgery.
People who experience chronic sleep disturbances may be at risk of developing dementia and Alzheimer’s disease at an earlier age.
Bariatric surgery can dramatically reduce an obese person's risk of all-cause mortality and nearly halve their risk of heart attack and stroke.
Compounds in peaches may inhibit the growth of breast cancer cells and their ability to spread.
Older people who have above-average muscle mass also have a significantly lower risk of dying from all-causes.
Chemotherapy may accelerate molecular aging to the equivalent to 15-years of normal aging.
Long after compulsory schooling ends, education continues to enhance cognitive functions.
A self-rated poor level of fitness in a person’s 50s may predict onset of dementia within the next three decades.